We came across a bullish thesis on Companhia De Saneamento Basico (NYSE:SBS) on ValueInvestorsClub by Nails4. In this article, we will summarize the bulls’ thesis on SBS. The company’s shares were trading at $14.90 when this thesis was published, vs. the closing price of $16.62 on Mar 07. A treatment plant with a large industrial wastewater treatment pipe in the foreground. SBS provides basic and environmental sanitation services in the São Paulo State, Brazil. The company supplies treated water and sewage services to residential, commercial, and industrial private customers, as well as the public. A high fiscal deficit and free fall of the Brazilian currency have made the equity markets one of the most performing ones. However, this also offers an opportunity to buy some good companies at a cheap valuation. The utility sector in Brazil offers a unique proposition where well-managed companies have provided compounding gains. Companies like SBS are allowed to levy rates based on WACC, opex, size of regulatory assets and expected volumes. The estimated costs are often different from the realized expenses, creating an opportunity for utility companies like SBS to earn supernormal profits. However, companies like Luz that operate in Rio, haven’t been able to manage costs well leading to a bankruptcy-like situation. SBS also benefits from the inflation adjustment of the regulatory asset base. This will allow the company to grow at least at the existing inflation rate. Another noteworthy development is the privatization of the company. The government has allowed SBS to estimate costs based on the 2022 cost structure when it was not really efficient. The new management has an interesting profile with expertise in cost reduction across companies. Based on the inflation rate of growth and accounting for depreciation and capex, the regulatory asset base is expected to triple in five years. Earnings are expected to quadruple due to higher revenue and better cost management. SBS offers a compelling growth story with an inflation hedge, rising ROIC, a deleveraged balance sheet and competent management. SBS could also become an acquisition target for Equatorial, one of the best-run utility firms in the country. This transaction should provide a better multiple for SBS if it performs well under the new management. While we acknowledge the potential of SBS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SBS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. Story Continues READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. View Comments
Companhia De Saneamento Basico (NYSE:SBS): Offering Utility in a Difficult Market
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...